What proportion of lung cancer in never-smokers can be attributed to known risk factors
International Journal of Cancer,

Sisti J et al. – The results demonstrate the geographic variability of the epidemiology of lung cancer in never–smokers and highlight the need for further research in this area, particularly in Europe and North America.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Oncology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Oncology Articles

1 Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial The Lancet, September 19, 2014    Evidence Based Medicine    Clinical Article

2 Bavituximab plus paclitaxel and carboplatin for the treatment of advanced non–small-cell lung cancer Lung Cancer, September 2, 2014    Clinical Article

3 Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer: A systematic review and meta-analysis of individual patient data The Lancet Oncology, September 24, 2014    Clinical Article

4 MET gene copy number predicts worse overall survival in patients with non-small cell lung cancer (NSCLC); a systematic review and meta-analysis PLOS ONE, September 23, 2014    Evidence Based Medicine

5 Clinical applications of circulating tumor cells in lung cancer patients by Cell Search system Frontiers in Oncology, September 25, 2014    Review Article

6 Association of cancer susceptibility variants with risk of multiple primary cancers: the Population Architecture using Genomics and Epidemiology study Cancer Epidemiology, Biomarkers & Prevention, September 10, 2014

7 Safety and effectiveness of bevacizumab-containing treatment for non–small-cell lung cancer: Final results of the ARIES observational cohort study Journal of Thoracic Oncology, September 16, 2014    Clinical Article

8 Relevance of gamma knife radiosurgery alone for the treatment of non-small cell lung cancer brain metastases Clinical Neurology and Neurosurgery, August 22, 2014    Clinical Article

9 Lung cancer: Is surgery an option for persisting N2 after induction therapy? Zentralblatt für Chirurgie - Zeitschrift für Allgemeine, Viszeral-, Thorax- und Gefäßchirurgie, August 18, 2014    Clinical Article

10 Comparison of therapeutic results from radiofrequency ablation and stereotactic body radiotherapy in solitary lung tumors measuring 5 cm or smaller International Journal of Clinical Oncology, September 9, 2014    Clinical Article

11 Quinacrine overcomes resistance to erlotinib by inhibiting FACT, NF-κB, and cell-cycle progression in non–small cell lung cancer Molecular Cancer Therapeutics, September 11, 2014    Clinical Article

12 Randomized phase III trial of erlotinib versus docetaxel as second- or third-line therapy in patients with advanced non-small-cell lung cancer: Docetaxel and Erlotinib Lung Cancer Trial (DELTA) Journal of Clinical Oncology, May 29, 2014    Clinical Article

13 Accuracy of FDG-PET to diagnose lung cancer in areas with infectious lung disease: a meta-analysis JAMA, September 25, 2014    Evidence Based Medicine    Clinical Article

14 Docetaxel or pemetrexed with or without cetuximab in recurrent or progressive non-small-cell lung cancer after platinum-based therapy: a phase 3, open-label, randomised trial The Lancet Oncology, January 24, 2014    Clinical Article

15 Prolongation of overall survival in advanced lung adenocarcinoma patients with the XAGE1 (GAGED2a) antibody Clinical Cancer Research, September 26, 2014    Clinical Article

16 Weekly and every 2 weeks cetuximab maintenance therapy after platinum-based chemotherapy plus cetuximab as first-line treatment for non-small cell lung cancer: Randomized non-comparative phase IIIb NEXT trial Targeted Oncology, September 29, 2014    Clinical Article

17 Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): An open-label, randomised, multicentre, phase 2 study The Lancet Oncology, September 9, 2014    Clinical Article

18 Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial The Lancet, June 4, 2014    Evidence Based Medicine    Clinical Article

19 Non-invasive diagnosis of actionable mutations by deep sequencing of circulating-free DNA in non-small cell lung cancer: Findings from BioCAST / IFCT-1002 Clinical Cancer Research, September 5, 2014    Clinical Article

20 Antitumor effect of traditional Chinese herbal medicines against lung cancer Anti-Cancer Drugs, September 17, 2014    Review Article

Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncologymore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More